Metacare Co (118000.KS) Stock Price

Metacare Co Price

CLOSED
1,191.00
​
Market closed

Over the last 16 years Metacare Co grew revenue by 15.2% annually, reaching 32.82 B KRW. Earnings per share have declined at 8.4% per year over the last 16 years. For Metacare Co, the net margin of 1.5% is down versus 41.6% a few years ago.

Metacare Co stock price

Access this data via the Eulerpool API

Metacare Co business model & stock analysis

MEDIPHARM Co., Ltd. engages in the manufacture, distribution, and sale of medical devices, and healthcare products. The company is headquartered in Hwaseong, Gyeonggi-Do. The company went IPO on 2009-12-30. The firm operates through five segments. The Pharmaceuticals Business segment is engaged in the distribution of pharmaceuticals including recapsules and tablets. The Medical Business segment is engaged in the distribution of medical devices and medical supplies. The Wireless Device segment is engaged in the manufacture of wearable wireless devices. The Video Content segment is engaged in the production of video products. The Investment segment is engaged in the management consulting and investment businesses.

Frequently asked questions about Metacare Co

Converted at the current exchange rate, the Metacare Co share trades at 0.79 EUR (1,191.00 KRW).

The revenue cannot currently be calculated for Metacare Co.

The profit cannot currently be calculated for Metacare Co.

The P/E ratio cannot be calculated for Metacare Co at the moment.

The P/S cannot be calculated for Metacare Co currently.

The Eulerpool Quality Score for Metacare Co is 5/10.

The ISIN of Metacare Co is KR7118000009. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Metacare Co is 118000.KS. The ticker symbol is used to trade Metacare Co shares on the stock exchange.

Fair ValueTerminal
1,048.08 KRW
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Health Care Providers & Services
Number of shares
Employees
Revenue per Employee
1.09 B KRW
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Country
South Korea
Currency
KRW
Initial public offering
Dec 30, 2009
ISIN
KR7118000009
Cusip
Y969DV106
Market capitalization
180.21 B KRWLarge Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/S
P/Se
—
EV/EBIT
152.18
P/B Ratio
1.51
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
0.35 %
Last updated Oct 12, 2026, 3:18 AM

Metacare Co Peer Group

Metacare Co FIGI

118000:KS · BBG000PCX3X6118000:KP · BBG000PCX4N5

All fundamentals and in-depth analysis of Metacare Co

Our stock analysis for Metacare Co stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Metacare Co. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.